Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse
PV Barnett, AR Samuel, L Pullen, D Ansell, RN Butcher and RM Parkhouse Institute for Animal Health, Pirbright Laboratory, Surrey, UK. paul.barnett@bbsrc.ac.uk Eight neutralizing and two non-neutralizing anti-foot-and-mouth disease virus (FMDV) bovine IgG1 and IgG2 monoclonal antibodies (BMAbs) recog...
Gespeichert in:
Veröffentlicht in: | Journal of general virology 1998-07, Vol.79 (7), p.1687-1697 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PV Barnett, AR Samuel, L Pullen, D Ansell, RN Butcher and RM Parkhouse
Institute for Animal Health, Pirbright Laboratory, Surrey, UK. paul.barnett@bbsrc.ac.uk
Eight neutralizing and two non-neutralizing anti-foot-and-mouth disease
virus (FMDV) bovine IgG1 and IgG2 monoclonal antibodies (BMAbs) recognize
conformationally dependent epitopes. The majority of those shown to
neutralize virus passively protected mice from virus challenge, regardless
of isotype. Well-characterized anti-FMDV mouse MAbs, representing five
independent neutralizing epitopes on O1 serotype virus, were examined with
each of the ten BMAbs in a competition-based ELISA. Five of the
neutralizing BMAbs (C48, C65, C74, C83 and MH6) were shown to be directed
against epitopes on, or in close proximity to, that previously defined as
neutralizing antigenic site 2. Another neutralizing BMAb, MH5, bound to an
epitope on, or in close proximity to antigenic site 3. Two neutralizing
BMAbs (C2 and C96) simultaneously abrogated the binding of mouse antibodies
to sites 2 and 4, contesting the autonomous nature of these two regions.
None of the BMAbs were shown to be directed towards the immunodominant
antigenic site 1. Sequence analyses of neutralization escape mutants
supported the competition ELISA results, and included changes at site 2
(VP2 aa C78Y), site 3 (VP1 N46S) and site 4 (VP3 E58K). Additionally, a
substitution at a previously unrecorded location (VP2 aa T1881) prevented
the binding of site 2 (C48) and sites 2 and 4 (C2) directed BMAbs. Although
the bovine and murine anti-FMDV repertoires may not be identical these
results support the recognition of similar antigenic features. This is the
first report characterizing anti-FMDV MAbs produced from a natural target
host, the cow. |
---|---|
ISSN: | 0022-1317 1465-2099 |
DOI: | 10.1099/0022-1317-79-7-1687 |